Palogic Value Management L.P. Invests $1.74 Million in Procter & Gamble Company (The) $PG

Palogic Value Management L.P. bought a new stake in Procter & Gamble Company (The) (NYSE:PG) in the second quarter, HoldingsChannel reports. The fund bought 11,876 shares of the company’s stock, valued at approximately $1,741,000.

Several other institutional investors have also recently made changes to their positions in PG. E Fund Management Hong Kong Co. Ltd. lifted its stake in Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares during the last quarter. Park Square Financial Group LLC grew its holdings in Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after buying an additional 71 shares in the last quarter. Evolution Wealth Management Inc. grew its stake in shares of Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after acquiring an additional 171 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Procter & Gamble during the second quarter worth approximately $26,000. Finally, Litman Gregory Wealth Management LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $26,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on PG. Sanford C. Bernstein restated a “market perform” rating and set a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. HSBC reiterated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Argus cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Citigroup lowered their target price on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Finally, Jefferies Financial Group raised their target price on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a report on Friday, June 26th. Thirteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.19.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 2,238 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $321,802.02. Following the completion of the transaction, the insider directly owned 26,989 shares in the company, valued at $3,880,748.31. This trade represents a 7.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew W. Janzaruk sold 359 shares of the business’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 6,627 shares of company stock valued at $953,417 in the last 90 days. Insiders own 0.20% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $143.71 on Friday. The firm has a market capitalization of $334.04 billion, a PE ratio of 21.71, a price-to-earnings-growth ratio of 4.43 and a beta of 0.39. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The firm’s 50 day simple moving average is $147.11 and its 200 day simple moving average is $148.28. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG) last announced its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. During the same period last year, the firm posted $1.48 earnings per share. Procter & Gamble’s quarterly revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were given a $1.0885 dividend. The ex-dividend date was Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is presently 65.71%.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.